Polar Capital Global Healthcare Trust plc (PCGH) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.003x

Based on the latest financial reports, Polar Capital Global Healthcare Trust plc (PCGH) has a cash flow conversion efficiency ratio of -0.003x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-1.22 Million ≈ $-147.95 USD) by net assets (GBX377.05 Million ≈ $45.88K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Polar Capital Global Healthcare Trust pl for the company's overall valuation and market capitalisation.

Polar Capital Global Healthcare Trust plc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Polar Capital Global Healthcare Trust plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Polar Capital Global Healthcare Trust plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Polar Capital Global Healthcare Trust plc ranked by their cash flow conversion efficiency. Explore cash flow quality index of Polar Capital Global Healthcare Trust pl to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Cahaya Bintang Medan Tbk Pt
JK:CBMF
0.000x
Union Pioneer Public Company Limited
BK:UPF
-0.058x
NuCana PLC
NASDAQ:NCNA
-0.038x
Euro Menkul Kiymet Yatirim Ortakligi AS
IS:EUYO
0.005x
APB Resources Bhd
KLSE:5568
0.041x
Avricore Health Inc
V:AVCR
-0.130x
COLLPLANT BIOTECH. IS-01
F:CPT
-0.624x
Philly Shipyard ASA
OL:PHLY
-4.976x

Annual Cash Flow Conversion Efficiency for Polar Capital Global Healthcare Trust plc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Polar Capital Global Healthcare Trust plc from 2012 to 2025. View Polar Capital Global Healthcare Trust pl (PCGH) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-09-30 GBX448.11 Million
≈ $54.52K
GBX-1.43 Million
≈ $-173.87
-0.003x -5192.46%
2024-09-30 GBX479.07 Million
≈ $58.29K
GBX30.00K
≈ $3.65
0.000x +101.15%
2023-09-30 GBX419.18 Million
≈ $51.00K
GBX-2.29 Million
≈ $-278.51
-0.005x +40.95%
2022-12-31 GBX404.83 Million
≈ $49.26K
GBX-3.74 Million
≈ $-455.54
-0.009x 0.00%
2022-09-30 GBX404.83 Million
≈ $49.26K
GBX-3.74 Million
≈ $-455.54
-0.009x -129.82%
2021-12-31 GBX422.19 Million
≈ $51.37K
GBX-1.70 Million
≈ $-206.72
-0.004x +8.64%
2021-09-30 GBX385.73 Million
≈ $46.93K
GBX-1.70 Million
≈ $-206.72
-0.004x -110.89%
2020-12-31 GBX360.54 Million
≈ $43.87K
GBX14.58 Million
≈ $1.77K
0.040x -9.82%
2020-09-30 GBX325.13 Million
≈ $39.56K
GBX14.58 Million
≈ $1.77K
0.045x +1110.61%
2019-09-30 GBX288.45 Million
≈ $35.10K
GBX-1.28 Million
≈ $-155.74
-0.004x -109.19%
2018-09-30 GBX296.26 Million
≈ $36.05K
GBX14.30 Million
≈ $1.74K
0.048x +130.98%
2017-09-30 GBX250.13 Million
≈ $30.43K
GBX-38.99 Million
≈ $-4.74K
-0.156x -452.71%
2016-09-30 GBX247.82 Million
≈ $30.15K
GBX10.95 Million
≈ $1.33K
0.044x +22.77%
2015-09-30 GBX210.44 Million
≈ $25.60K
GBX7.58 Million
≈ $921.66
0.036x +154.94%
2014-09-30 GBX199.96 Million
≈ $24.33K
GBX-13.10 Million
≈ $-1.59K
-0.066x -81.49%
2013-09-30 GBX155.75 Million
≈ $18.95K
GBX-5.62 Million
≈ $-684.16
-0.036x -19.85%
2012-09-30 GBX120.74 Million
≈ $14.69K
GBX-3.64 Million
≈ $-442.52
-0.030x --

About Polar Capital Global Healthcare Trust plc

LSE:PCGH UK Asset Management
Market Cap
$5.49 Million
GBX45.11 Billion GBX
Market Cap Rank
#28495 Global
#458 in UK
Share Price
GBX438.00
Change (1 day)
-0.90%
52-Week Range
GBX348.00 - GBX457.50
All Time High
GBX457.50
About

Polar Capital Global Healthcare Trust plc is a closed ended equity mutual fund launched and managed by Polar Capital LLP. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on companies involved in pharmaceuticals, medical services, medical devices, and biotechnology. The fund primarily invests… Read more